Last reviewed · How we verify
NCT03220620
Influence of Perioperative Fluid Therapy on Hemoglobin and Methemoglobin Levels
trial testing GDT in Perioperative/Postoperative Complications in 60 participants. Completed in 1 January 2020.
31 December 2019
Quick facts
| Lead sponsor | University of Rostock |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 60 |
| Start date | 14 July 2017 |
| Primary completion | 31 December 2019 |
| Estimated completion | 1 January 2020 |
| Sites | 1 location across Germany |
Drugs / interventions tested
- GDT
Conditions studied
- Perioperative/Postoperative Complications — all drugs for Perioperative/Postoperative Complications →
- Fluid Overload — all drugs for Fluid Overload →
- Hemoglobin H — all drugs for Hemoglobin H →
Sponsor
University of Rostock
Who can join
Adults 18 to 90, any sex, with Perioperative/Postoperative Complications or Fluid Overload. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The objective of the study is to evaluate influence of perioperative fluid therapy on Methemoglobin levels, and to changes in hemoglobin. Further, changes in Methemoglobin will be related to metabolic signs of oxidative stress (changes in blood lactate). Patients undergoing major abdominal surgery will be included into the study.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03220620
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of GDT
Trials testing the same drug.
- NCT06231901 — Comparison of CO-OP and GDT on Occupational Performance and Functional Status in the CP · NA · completed
- NCT04547491 — Hypotension Prediction With HPI Algorithm During Major Gynecologic Oncologic Surgery · NA · completed
Other recruiting trials for Perioperative/Postoperative Complications
Currently open trials in the same condition.
- NCT06945341 — International Focus Group Discussion on Neuromuscular Monitoring. · recruiting
- NCT06862115 — The Effect of Discontinuation of Renin Angiotensin System Inhibitors on the Perioperative Myocardial Injury in Adult Pat · Phase 3 · recruiting
- NCT06501157 — Establishment of Emergency Surgery Triage and Checklist Management System · active not recruiting
- NCT06166706 — Current Practice of Ventilation Strategies in Children Undergoing General Anesthesia · recruiting
- NCT06042699 — Kids With Iron Deficiency and Scoliosis · NA · recruiting
Other University of Rostock trials
Trials by the same sponsor.
- NCT06489470 — Strokectomy in Malignant Cerebral Media Infarction · NA · recruiting
- NCT06175429 — Prognostic Value of Exhaled Isoprene Levels for Morbidity and Functional Outcome in Cardiosurgical Patients · unknown
- NCT04972617 — Characterization of the Efficacy of Furosemide Depending on Albumin Function · completed
- NCT06318208 — Pulmonary Function in Non-hospitalized Adults and Children After Mild COVID-19 · completed
- NCT05885620 — SAMi Intervention Study to Evaluate Smartwatch Interventions in Persons With MCI and Dementia · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03220620 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Rostock
- Last refreshed: 3 November 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03220620.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing